Safety Guide
GLP-1 Medication Arrived Warm? What to Do by Brand (2026)
Bottom line up front
If your refrigerated injectable GLP-1 arrived warm, do not inject it yet. Put it back in the fridge, take photos of the box and ice packs, and check the manufacturer's room-temperature limit for your exact product. If your GLP-1 is a tablet — Rybelsus, Wegovy oral, or Foundayo — those are room-temperature products and follow different rules.
Most FDA-approved injectable brands allow some room-temperature time: Ozempic up to 56 days, Wegovy injection up to 28 days, Mounjaro and Zepbound single-dose pens up to 21 days, Trulicity up to 14 days. The real question is whether your package stayed under the manufacturer's ceiling — not whether the ice packs are melted.
What "Arrived Warm" Actually Means
Quick answer: "Warm" is not a single thing. It can mean ice packs that are no longer frozen but the box is still cool. It can mean a vial that feels warm on a hot porch. It can mean a package delayed for two days. Each of those situations has a different answer, and the manufacturer guidance for every FDA-approved injectable GLP-1 covered here allows a window of room-temperature time. The real question is whether your package stayed under the manufacturer's ceiling — not whether something feels warm.
Here's what most pages get wrong. They tell you "warm = ruined, throw it out." That's not what the manufacturers actually say.
Novo Nordisk's medical information site states that Ozempic can be used as long as it has not been below 36°F or above 86°F. If it was exposed above 46°F, you have to use or discard it within 56 days. Eli Lilly's prescribing information for Mounjaro and Zepbound states the same 86°F ceiling, with a 21-day window for single-dose pens and vials and a 30-day window for multi-dose vials or the KwikPen. These are published storage limits backed by stability testing the FDA reviewed.
So when you open a box that feels warm, two questions decide what happens next:
Melted ice packs are not the same as ruined medication
Some pharmacies design their shipments so insulation and cold packs work together — a melted ice pack on its own does not automatically prove the medication exceeded the labeled limit. Hone Health's published support page says melted ice packs can be expected in warmer months and don't necessarily mean the medication is unsafe if the package arrived on time and doesn't feel warm to the touch. That depends on the pharmacy's packaging validation and the shipment timeline, though — not just the fact that an ice pack melted.
Warm and hot are different
The manufacturer ceiling for nearly every injectable GLP-1 covered here is 86°F. Room temperature in a normal house is 68° to 75°F. Mid-day in a closed delivery vehicle in July can hit 110°F. Those are wildly different situations even though all of them feel "warm" to a person who just expected a cold package. Where you can, get a real number — some specialty pharmacies include a temperature indicator strip or data logger in the box.
What to Do in the First 5 Minutes
Quick answer: Pause before you inject. Get the medication into the right storage condition for its form, photograph the package, identify the exact product, and check the manufacturer's window for that product. If anything is unclear, call the dispensing pharmacy before you use it.
This is the part where panic costs people money. They either inject because their dose is due, or they throw the medication straight in the trash. Both are mistakes. Slow down for ten minutes and you'll likely save the medication or get a clean replacement.
Don't inject yet
The dose can wait an hour. The medication can't unspoil itself. Whatever happens next, the next thing should not be an injection.
Get it to the right storage condition
For refrigerated injectables (Ozempic, Wegovy injection, Mounjaro, Zepbound, Trulicity, Saxenda, Victoza, and most compounded products): move it to the fridge while you sort out next steps. But know: refrigerating it does not erase the room-temperature time it already had. Eli Lilly's guidance for the Mounjaro KwikPen and Trulicity tracks total cumulative time outside the fridge — putting it back in cold storage stops the clock, it doesn't roll it back. For tablets (Rybelsus, Wegovy oral, Foundayo): do not refrigerate. Keep them in the original bottle at room temperature. Cold can introduce moisture that damages tablets.
Take photos
Before you do anything else, photograph: the outside of the box including the shipping label; the ice packs (showing whether they're still cold, slushy, or fully liquid); the medication carton; the vial, pen, or bottle; the lot number and expiration date on the label; any temperature strip or indicator inside the box. If your phone shows a delivery time stamp on the photo, even better.
Pull the tracking history
Open your tracking page and screenshot the full transit history. Look for: how long was it in transit? Were there any delay or exception notes? What time was it delivered? How long did it sit before you opened it? A two-day shipment that took four days because of a weather delay is documented evidence to send the pharmacy.
Identify the exact product
A "Mounjaro pen" can be a single-dose pen (21-day room-temperature window) or a single-patient-use KwikPen (30-day window). A "Zepbound vial" can be a single-dose vial (21 days) or a multi-dose vial (30 days). Wegovy can be the injection or the new Wegovy oral tablet — completely different storage rules. Find the exact form on the carton. Then go to the right row in the matrix below.
Check the manufacturer's window
Match your product to the brand-by-brand matrix below. If your situation appears to fall inside the labeled window, you may have something usable. If it falls outside or you can't tell, the answer is the same: call the pharmacy.
Brand-by-Brand Temperature Limits
Quick answer: Most current FDA-approved injectable GLP-1 products have a product-specific room-temperature allowance, but the rule changes by product and form. Oral tablets follow room-temperature, moisture, and light-protection rules instead. Every row is sourced from current manufacturer prescribing information, last verified May 7, 2026.
This is the part you'd otherwise spend an hour assembling from manufacturer PDFs.
| Medication | Active drug | Maker | Refrigerated storage | Room-temp allowance | Ceiling | Window | Notes |
|---|---|---|---|---|---|---|---|
| Ozempic | semaglutide | Novo Nordisk | 36°F – 46°F | Allowed at non-refrigerated temperatures | 86°F | 56 days | Use or discard within 56 days if exposed above 46°F |
| Wegovy injection | semaglutide | Novo Nordisk | 36°F – 46°F | 46°F – 86°F for up to 28 days before cap removal | 86°F | 28 days | Single-dose pen |
| Wegovy oral tablets | semaglutide | Novo Nordisk | n/a | 68°F – 77°F; excursions permitted 59°F – 86°F | 86°F | n/a — tablet | Original bottle, dry, no refrigeration |
| Rybelsus tablets | semaglutide | Novo Nordisk | n/a | 68°F – 77°F; excursions permitted 59°F – 86°F | 86°F | n/a — tablet | Original bottle, dry |
| Foundayo tablets | orforglipron | Eli Lilly | n/a | 68°F – 77°F; excursions permitted 59°F – 86°F | 86°F | n/a — tablet | Original bottle/carton; protect from light. FDA-approved April 2026 |
| Mounjaro single-dose pen / single-dose vial | tirzepatide | Eli Lilly | 36°F – 46°F | Up to 86°F for up to 21 total days | 86°F | 21 days cumulative | Once at room temp, the time counts even if returned to the fridge |
| Mounjaro multi-dose vial / KwikPen (unopened) | tirzepatide | Eli Lilly | 36°F – 46°F | Up to 86°F | 86°F | 30 days | Different rule from single-dose |
| Mounjaro multi-dose vial / KwikPen (opened) | tirzepatide | Eli Lilly | Either fridge or up to 86°F | Up to 30 days | 86°F | 30 days OR 4 weekly doses, whichever comes first | In-use rules |
| Zepbound single-dose pen / single-dose vial | tirzepatide | Eli Lilly | 36°F – 46°F | Up to 86°F for up to 21 total days | 86°F | 21 days cumulative | Same structure as Mounjaro |
| Zepbound multi-dose vial / KwikPen | tirzepatide | Eli Lilly | 36°F – 46°F | Up to 86°F; 30 days unopened. 30 days or 4 doses once in use | 86°F | 30 days | Same structure as Mounjaro |
| Trulicity | dulaglutide | Eli Lilly | 36°F – 46°F | Up to 86°F for up to 14 cumulative days | 86°F | 14 days cumulative | The 14 days can be split, but cannot reset by re-refrigerating |
| Saxenda / Victoza / generic liraglutide | liraglutide | Novo Nordisk (and generic makers) | 36°F – 46°F | Allowed if not below 36°F or above 86°F | 86°F | 30 days if exposed above 46°F | Generic versions launched 2024–2025; check the carton and PI for your specific product |
| Byetta | exenatide | AstraZeneca | 36°F – 46°F before first use | Below 77°F after first use only | 77°F (after first use) | 30 days from first use | Discontinued in the U.S. October 2024; included for legacy/non-US searchers |
| Bydureon BCise | exenatide ER | AstraZeneca | 36°F – 46°F | Up to 86°F for no more than 4 total weeks | 86°F | 4 weeks | Suspension — should appear cloudy after mixing. Discontinued in the U.S. October 2024 |
| Adlyxin | lixisenatide | Sanofi | 36°F – 46°F (unused pens) | Up to 86°F for 14 days after activation only | 86°F (after activation) | 14 days after activation | No longer routinely available in the U.S. |
Source: current manufacturer prescribing information. Blue rows = tablet products (no cold-chain required). Grayed rows = discontinued in U.S.
The room-temperature window is for your use. Eli Lilly's published medical information for both Mounjaro and Trulicity makes this explicit: wholesalers, pharmacies, and distribution centers cannot use any part of the patient's room-temperature allowance. That 21-day, 14-day, or 30-day window was designed to give you flexibility for travel and dose timing — not to absorb a failed cold chain. Label room-temperature allowance is not proof that a failed shipment stayed inside the validated range.
The ceiling is what fails first. A package exposed to 95°F or 105°F is outside the manufacturer's window even if it was only there for an hour. Time and temperature both matter, and the temperature ceiling is the harder line.
Byetta and Adlyxin's room-temp rules apply after first use only. A new unused Byetta or Adlyxin pen that arrived warm is not cleared by the after-first-use rule. If you have one of these, contact the pharmacy.
What if My GLP-1 Is a Tablet, Not an Injection?
Quick answer: Rybelsus, Wegovy oral, and Foundayo are not cold-chain shipments. They're stored at room temperature with label-specific moisture and light protection rules, so a "warm-arrival" question for a tablet is really about heat exposure beyond the labeled excursion range, bottle integrity, and moisture — not melted ice packs.
Both Rybelsus and Wegovy oral are stored at 68°F to 77°F with excursions permitted from 59°F to 86°F, in the original bottle, kept dry. Foundayo (orforglipron, FDA-approved April 1, 2026) follows the same temperature window and adds a light-protection requirement, kept in the original bottle or carton.
If a tablet shipment arrived warm:
- Don't refrigerate it. Cold can introduce moisture that damages tablets, and refrigeration is not the labeled storage condition.
- Check the bottle. The desiccant (the small packet inside) should still be present. The bottle should still be sealed if you haven't opened it. Damage to the bottle is a stop sign.
- Check the temperature exposure. If the package was clearly above 86°F for any extended period — a hot car, a porch in the sun all day — that's outside the labeled excursion range, and the pharmacy should make the call.
- For Foundayo specifically, check that the bottle/carton kept the tablets dark. Foundayo's label requires light protection.
If you're unsure, call the pharmacy with your photos and tracking history. The bigger risks for tablets are moisture and damaged packaging, not temperature alone.
Compounded vs. Brand-Name: Why the Rules Are Different
Quick answer: Compounded semaglutide and tirzepatide are not FDA-approved. Their stability data comes from the compounder, not from a uniform regulatory submission. The FDA recommends not using any injectable GLP-1 that arrives warm or with insufficient refrigeration because quality can be affected. If your warm-arrival shipment is compounded, the pharmacy that made it is the only place that can give you a stability decision.
What major compounded GLP-1 providers say (provider-stated, not FDA-reviewed)
| Provider | Product | What the provider's published page says | Source |
|---|---|---|---|
| Hims | Compounded semaglutide | Stable up to 95°F for up to 4 days, or up to 77°F for up to 15 days | Hims Support |
| Hone Health | GLP-1 therapies | Melted ice packs can be common in warmer months; medication is likely still effective if arrived on time and does not feel warm; tells users to contact the care team if the medication feels warm or hot | Hone Health Support |
| Goby Meds | Compounded semaglutide | Refrigerate at 36°F–46°F; permits limited room-temperature exposure during use; some compounded versions may have stability up to 77°F for 60 days per Goby's published guidance | Goby Meds Article |
| Eden | Compounded semaglutide | Refrigerate at 36°F–46°F before first use; after opening, refrigerator or room temperature 59°F–86°F per pharmacy guidance | Eden Provider Page |
| Henry Meds | GLP-1 injectables (often shipped as lyophilized powder) | GLP-1 medication needs to be refrigerated after delivery; check the specific pharmacy's instructions for your shipment format | Henry Meds Support |
Do not use this table to self-clear a compounded vial. Use it to ask the pharmacy a sharper question — and get the answer in writing.
What about lyophilized (freeze-dried) compounded GLP-1?
Some providers ship compounded semaglutide or tirzepatide in lyophilized form — a freeze-dried powder that you mix with bacteriostatic water before injecting. If your shipment is a powder rather than a liquid, do not apply the liquid-vial rules automatically. Check the pharmacy label and contact the provider before using it if it arrived warm.
How to Inspect the Medication
Quick answer: Most brand-name injectable GLP-1s should be clear and colorless or slightly yellow, with no particles, no cloudiness, and no signs of freezing, leakage, or damage. Bydureon BCise is the one major exception — it's a suspension that should appear cloudy after mixing. Visual inspection catches obvious failures, but it cannot prove a warm shipment stayed potent.
Healthy clear-solution GLP-1s look like
Applies to: Ozempic, Wegovy injection, Mounjaro, Zepbound, Trulicity, Saxenda, Victoza, Byetta, Adlyxin
- Clear and colorless, or slightly yellow (Mounjaro and Zepbound are described in their PI as "clear, colorless to slightly yellow")
- Free of particles, sediment, or visible specks
- Free of cloudiness or haziness
- Inside an undamaged pen or vial with no cracks or leaks
⚠️ Bydureon BCise is different
Bydureon BCise is an injectable suspension. After mixing it should appear as an opaque, cloudy, white to off-white suspension — that cloudiness is the medicine in suspension, not a sign of damage. If you're a Bydureon BCise user and you discard a "cloudy" pen because of a generic checklist, you're throwing away medication that's working as designed.
Frozen is always discard
Look for ice crystals, separated layers in the liquid, or a vial that was clearly cold enough to freeze. Manufacturers state that GLP-1 injectables damaged by freezing should not be used — freezing damage can persist after thawing even when the medication looks normal.
Visible inspection isn't a complete safety test
A vial that was held above 86°F for hours can look completely normal. That's why the manufacturer's storage thresholds exist — they were validated by laboratory stability testing, not by what you can see. A "looks fine" vial that was outside its temperature window is not the same as a vial confirmed inside the labeled range. Visual inspection is necessary, not sufficient.
What if There's a Temperature Strip or Data Logger in the Box?
Quick answer: Photograph it before moving or discarding anything, then send the reading to the pharmacy with the delivery timeline. A temperature logger is stronger evidence than how the box felt because it can show whether the medication stayed inside the validated shipping range.
Check the box (including under the insulation) for any of these:
If you find one:
- 1. Photograph it before you move it. Capture the threshold, any indicator state, and any visible reading.
- 2. Don't throw it away. The pharmacy may need it for the stability review.
- 3. Send the photo to the pharmacy. A triggered indicator is the cleanest evidence you can give them.
What if the Ice Packs Were Melted but the Box Doesn't Feel Hot?
Quick answer: Melted ice packs alone do not prove the medication exceeded the manufacturer's ceiling. Make the decision based on the exact product, the labeled allowance, the delivery timeline, the temperature inside the box if you have a reading, and the dispensing pharmacy's policy.
This is the most common summer scenario. You open a box, the ice packs are slush or fully liquid, but the medication itself feels close to room temperature. Here's a practical decision framework.
You may be inside the manufacturer-allowed window if ALL THREE are true
- 1.Your product has a labeled room-temperature window (most do — see the matrix above)
- 2.You can reasonably estimate that the package stayed at or below 86°F
- 3.The medication looks normal — clear and colorless or slightly yellow, no particles, no damage, no signs of freezing
Call the pharmacy if ANY of these are true
- The product is compounded
- The package was delayed beyond the original delivery window
- The package sat outside in direct sun
- The vial or pen feels distinctly warm (not just room-temperature)
- There's no temperature monitor and the climate that day was hot
- Your dose is due today and you want a written stability determination
- You have any visual concern about the medication itself
- It was a high-value shipment (multi-month supply, expensive specialty pharmacy product)
The pharmacy's job here is to make the determination, not yours. They have the validated shipping data, the stability information, and the ability to issue a replacement if needed. Your job is to give them the right facts.
How to Get a Replacement
Quick answer: Refrigerate the medication, gather your photos and tracking history, and contact the dispensing pharmacy as soon as possible — ideally the same day. Many pharmacies require prompt documentation before they'll review a warm-arrival shipment. Lead with facts, not just "it was warm."
The single biggest factor in whether you get a replacement is how well-documented your request is.
Have these ready before you call or email:
- Your name and order number
- Medication, brand, form (single-dose pen, multi-dose vial, KwikPen, etc.)
- Lot number from the label
- Expiration date
- Delivery date and time
- The time you opened the package
- Outside temperature that day
- Ice-pack condition (frozen / partially frozen / liquid / warm)
- How the medication itself feels and looks
- Temperature logger or strip reading if one was included
- Photos of all of the above
- Whether your dose is due today
Phone script you can use
"Hi, my name is [your name] and I'm calling about a GLP-1 medication that arrived warm. The product is [brand and form], delivered on [date] at [time]. The ice packs were [condition] and the medication feels [condition]. I have photos of the package, the ice packs, the lot number, the expiration date, and the tracking history. I need a stability determination — can you confirm whether this shipment stayed inside the validated temperature range, or do I need a replacement?"
Email / support-ticket template
Hi,
My most recent shipment arrived warm and I need a determination before I use it. Details below:
- - Patient name: [name]
- - Order or prescription number: [number]
- - Medication / brand / form: [e.g. Mounjaro single-dose pen, 5 mg]
- - Lot number: [from label]
- - Expiration date: [from label]
- - Delivered at: [date and time]
- - Opened at: [date and time]
- - Outside temperature on delivery day: [temperature]
- - Ice-pack condition on opening: [frozen / partially frozen / liquid / warm to the touch]
- - Medication condition on opening: [refrigerated / cool / room temperature / warm / hot]
- - Temperature monitor or logger reading (if included): [reading]
- - Photos attached: [yes — outer box, label, ice packs, medication, lot/exp]
- - Tracking history: [attached or summarized]
- - My next scheduled dose: [date]
I am requesting either:
- 1. Written confirmation that this shipment stayed inside the validated temperature range and remains within the labeled storage window through [date], or
- 2. A replacement shipped with cold-chain documentation
Please let me know what's needed to move this forward.
Thanks,
[your name]
If you bought through a telehealth platform
For compounded GLP-1s through Hims, Eden, MEDVi, Henry Meds, Ro, SHED, Sesame, Goby, Hone, or any other platform — start with the platform's support team. They route the request to the partner pharmacy. Don't try to call the compounding pharmacy directly unless the platform tells you to.
If the pharmacy won't resolve it — escalation order:
- 1.Your prescribing clinician — they can call the pharmacy on your behalf and document the issue
- 2.The manufacturer's medical information line — for brand-name products, Novo Nordisk and Eli Lilly both have professional medical information lines that can clarify storage thresholds
- 3.Your insurance or pharmacy benefit manager — if you cannot get a replacement before your next refill is approved
- 4.FDA MedWatch (fda.gov/medwatch) — for repeated cold-chain failures, suspected counterfeit product, or any adverse event you experienced
What if Your Dose Is Due Today?
Don't inject a questionable GLP-1 just because the calendar says it's time.
Contact your prescriber or pharmacist for missed-dose guidance specific to your medication, especially if you use it for type 2 diabetes or take insulin, sulfonylureas, or other glucose-lowering medication. The right answer is product-specific and patient-specific, and it's not a self-serve call.
What to have ready when you message your prescriber:
- Your medication and current dose
- Date of last dose
- Date of next scheduled dose
- Current symptoms, if any
- Recent blood glucose readings (for diabetes patients)
- What happened with the shipment
- What the pharmacy said so far
Most prescribers can handle this with a quick portal message. Don't tough it out and don't guess.
Should You Throw the Medication Away?
Quick answer: Not yet. Don't discard medication until either the pharmacy tells you to, or you've already gotten the replacement question resolved. You may need the box, label, lot number, and the medication itself for the pharmacy's review and any FDA quality report.
This is a small thing that costs people money. They're upset, they want the warm medication out of their fridge, so they trash it. Then the pharmacy asks for the lot number and the medication is in a landfill.
While the case is open, keep:
- The outer box and shipping label
- The medication carton with the lot number visible
- The medication itself, in the labeled storage condition
- Your photos and tracking screenshots in one folder
- The ice packs — their condition is part of the documentation
Disposal when the pharmacy authorizes it
For unused medication that needs to be discarded, the FDA's preferred path is a drug take-back program. Many pharmacies, including most major chains, accept unused medications.
For used pens, vials, or syringes (sharps), place them immediately in an FDA-cleared sharps disposal container. If you don't have one, FDA guidance says a heavy-duty plastic household container with a tight-fitting, puncture-resistant lid can work, properly labeled and disposed of according to your state's rules.
→ See our full GLP-1 needle and pen disposal guide for brand-by-brand sharps rules, free container options, and state laws.
What Actually Happens to a GLP-1 That Gets Too Warm
Quick answer: Heat exposure outside the labeled range can affect drug quality, which is why manufacturers set temperature limits and why the FDA warns against using injectable GLP-1s that arrive warm or with insufficient refrigeration. Visual inspection can catch obvious problems, but it can't prove a specific warm shipment stayed potent.
A GLP-1 receptor agonist works because the peptide molecule has a very specific shape that lets it dock with a receptor on cells in your body. Heat affects how that peptide holds together. Some heat is fine — that's why the manufacturer windows exist. Past a certain point, the protein structure can start to break down. The medication might still be present in the vial, but it's no longer doing its job.
The reason a vial can look completely fine after a heat event is that visible changes (cloudiness, color change, particles) are usually downstream signs of severe damage. Mild-to-moderate heat damage looks identical to a healthy vial. So when manufacturers say "discard if exposed above 86°F," they're not being overcautious — they did the stability testing, that's the limit, and you cannot eyeball it.
How to Prevent This From Happening Again
Quick answer: Most warm-arrival events are preventable with three changes — schedule deliveries when someone's home to put them in the fridge, request signature-required delivery, and pick a pharmacy with documented cold-chain controls and climate-appropriate packaging.
Schedule delivery when you'll be home
Porch dwell time is the most common quiet cold-chain failure. A package that left the warehouse cold can sit on your doorstep in afternoon sun for six hours and reach temperatures the shipper never tested for. Most carriers (FedEx, UPS, USPS) let you schedule delivery windows or hold packages for pickup at staffed locations. In summer, hold-for-pickup at a climate-controlled FedEx or UPS location can be safer than home delivery, especially in hot states.
Request signature-required delivery
Eliminates porch dwell time entirely. Your pharmacy or telehealth platform can usually set this on request. The trade-off is you have to be home or reschedule, but for a multi-month GLP-1 supply, that's a fair trade.
Ask what your pharmacy ships in
Not all packaging is equal. Some pharmacies use validated insulated shippers rated for specific summer/winter conditions and include data loggers. Others ship in basic insulated boxes with gel packs and hope for the best. If your shipments routinely arrive with melted ice packs, ask the pharmacy what their packaging is rated for. If you're in a hot climate (Arizona, Texas, Florida, Nevada in particular), this matters more.
Plan refills around weather
Heat waves, holiday weekends, and weather delays are the most common transit-time risks. If you can flex a refill date by a few days, avoid scheduling it right before a major holiday or in the middle of a forecast heat dome. Most pharmacies will let you fill a few days early.
Travel handling
If you're traveling with GLP-1, always carry it on — never check it. Checked baggage can be exposed to temperature extremes. Use a medical-grade insulated case and match the case's stated cold-hold time to your travel duration. The TSA allows medically necessary gel ice packs in reasonable quantities, even if melted or slushy. Bring your prescription label and you're fine at security.
Questions to ask your pharmacy before the next shipment
- →What's the validated transit duration for your summer packaging?
- →Do you include a temperature logger or indicator strip?
- →Do you ship over weekends, or hold until Monday?
- →Is signature-required delivery available?
- →What's your replacement policy for warm-arrival shipments?
- →Can I switch to hold-for-pickup at a FedEx or UPS location?
- →What counts as a documented cold-chain failure on your end?
Frequently Asked Questions
What We Verified
This page exists because the dominant advice on the open web — "if it arrived warm, throw it out" — disagrees with what the manufacturers themselves publish. Before we wrote any threshold above, we read the primary sources.
What we checked
- •FDA's published position on compounded GLP-1 drugs, including the warm-arrival warning, on fda.gov
- •Novo Nordisk Medical's Storage & Stability page for Ozempic, Wegovy injection, Wegovy oral, Rybelsus, Saxenda, and Victoza
- •Current Mounjaro and Zepbound prescribing information on DailyMed, including the single-dose vs. multi-dose distinction
- •Eli Lilly's published medical information for Mounjaro KwikPen storage, including the explicit statement that wholesalers and pharmacies cannot use any part of the room-temperature allowance
- •Current Trulicity storage guidance from Lilly Medical, including the 14-day cumulative cap
- •Foundayo (orforglipron) FDA approval announcement and Eli Lilly's storage labeling
- •Current Byetta and Adlyxin labels on DailyMed (both discontinued in the U.S.)
- •FDA-approved label for Bydureon BCise, including the suspension exception for visual inspection
- •Published support pages of major compounded GLP-1 telehealth providers (Hims, Hone Health, Goby Meds, Eden, Henry Meds)
- •TSA guidance on medically necessary gel ice packs and FDA guidance on drug disposal
What we didn't do
- •We did not pretend a "medical reviewer" reviewed this page when one did not
- •We did not invent author credentials
- •We did not add review or rating schema for content that doesn't have reviews
- •We did not guess at thresholds we couldn't source
Re-verification cadence
Quarterly during normal months; monthly during summer (May–September), when shipping conditions are most likely to push the limits.
One honest limitation: This page tells you what the manufacturer's published thresholds are. It cannot tell you what temperature your specific package reached. Only a temperature monitor inside the box, or your dispensing pharmacy's validated shipping data, can do that. When in doubt, the pharmacy is the decision-maker.
Sources
- •FDA — FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (fda.gov)
- •FDA — FDA Approves First New Molecular Entity Under National Priority Voucher Program (Foundayo / orforglipron)
- •Novo Nordisk Medical — GLP-1 RAs Storage & Stability (novonordiskmedical.com)
- •DailyMed — Mounjaro Prescribing Information
- •DailyMed — Zepbound Prescribing Information
- •Eli Lilly — How should the Mounjaro KwikPen be stored? (medical.lilly.com)
- •Lilly Medical — Trulicity storage guidance (medical.lilly.com)
- •Trulicity.lilly.com — Trulicity Storage & Safe Disposal
- •DailyMed — Byetta (exenatide) Prescribing Information
- •DailyMed — Adlyxin (lixisenatide) Medication Guide
- •FDA AccessData — Bydureon BCise label
- •UnitedHealthcare Provider — Discontinuation of Bydureon BCise and Byetta (October 2024)
- •Wegovy.com — Wegovy storage guidance
- •Ozempic.com — Ozempic storage guidance
- •FDA — MedWatch: The FDA Safety Information and Adverse Event Reporting Program (fda.gov/medwatch)
- •FDA — Where and How to Dispose of Unused Medicines (fda.gov)
- •FDA — Sharps Disposal Containers (fda.gov)
- •TSA — Gel Ice Packs (tsa.gov)
- •Hims Support — What if the ice packs in my Compounded Semaglutide package are melted?
- •Hone Health Support — What to Do If the Ice Pack Is Melted
- •Goby Meds — Storing GLP-1 Medications and Does Compounded Semaglutide Need to Be Refrigerated?
- •Eden — Semaglutide vial duration: understanding shelf life and usage
- •Henry Meds Support — Should my GLP-1 medication be refrigerated?
This page is a comparison resource and does not replace your pharmacist or prescriber's individual judgment. The thresholds above come from manufacturer published guidance and FDA primary sources; the editorial recommendations on what to do with a warm-arrival shipment are based on those thresholds plus standard pharmacy practice. If your dose is due and you're unsure whether to use a vial, contact your dispensing pharmacy or prescriber. For adverse events or suspected drug quality problems, report to FDA MedWatch at fda.gov/medwatch.